Cerebral microbleeds: a new dilemma in stroke medicine

Cerebral microbleeds (CMBs) are an increasingly common neuroimaging finding in the context of ageing, cerebrovascular disease and dementia, with potentially important clinical relevance. Perhaps the most pressing clinical question is whether CMBs are associated with a clinically important increase i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakar, Puneet, Charidimou, Andreas, Werring, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738371/
https://www.ncbi.nlm.nih.gov/pubmed/24175079
http://dx.doi.org/10.1177/2048004012474754
_version_ 1782476833684455424
author Kakar, Puneet
Charidimou, Andreas
Werring, David J
author_facet Kakar, Puneet
Charidimou, Andreas
Werring, David J
author_sort Kakar, Puneet
collection PubMed
description Cerebral microbleeds (CMBs) are an increasingly common neuroimaging finding in the context of ageing, cerebrovascular disease and dementia, with potentially important clinical relevance. Perhaps the most pressing clinical question is whether CMBs are associated with a clinically important increase in the risk of intracerebral haemorrhage (ICH), the most feared complication in patients treated with thrombolytic or antithrombotic (antiplatelet and anticoagulant) drugs. This review will summarize the evidence available regarding CMBs as an indicator of future ICH risk in stroke medicine clinical practice.
format Online
Article
Text
id pubmed-3738371
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-37383712013-10-30 Cerebral microbleeds: a new dilemma in stroke medicine Kakar, Puneet Charidimou, Andreas Werring, David J JRSM Cardiovasc Dis Review Cerebral microbleeds (CMBs) are an increasingly common neuroimaging finding in the context of ageing, cerebrovascular disease and dementia, with potentially important clinical relevance. Perhaps the most pressing clinical question is whether CMBs are associated with a clinically important increase in the risk of intracerebral haemorrhage (ICH), the most feared complication in patients treated with thrombolytic or antithrombotic (antiplatelet and anticoagulant) drugs. This review will summarize the evidence available regarding CMBs as an indicator of future ICH risk in stroke medicine clinical practice. SAGE Publications 2012-11-30 /pmc/articles/PMC3738371/ /pubmed/24175079 http://dx.doi.org/10.1177/2048004012474754 Text en © The Author(s) 2013 http://creativecommons.org/licenses/by-nc/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kakar, Puneet
Charidimou, Andreas
Werring, David J
Cerebral microbleeds: a new dilemma in stroke medicine
title Cerebral microbleeds: a new dilemma in stroke medicine
title_full Cerebral microbleeds: a new dilemma in stroke medicine
title_fullStr Cerebral microbleeds: a new dilemma in stroke medicine
title_full_unstemmed Cerebral microbleeds: a new dilemma in stroke medicine
title_short Cerebral microbleeds: a new dilemma in stroke medicine
title_sort cerebral microbleeds: a new dilemma in stroke medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738371/
https://www.ncbi.nlm.nih.gov/pubmed/24175079
http://dx.doi.org/10.1177/2048004012474754
work_keys_str_mv AT kakarpuneet cerebralmicrobleedsanewdilemmainstrokemedicine
AT charidimouandreas cerebralmicrobleedsanewdilemmainstrokemedicine
AT werringdavidj cerebralmicrobleedsanewdilemmainstrokemedicine

Ejemplares similares